|
US2015320699A1
|
|
Pharmaceutical composition containing lutein and antioxidant for treating and preventing human disease
|
|
US2011097415A1
|
|
Pharmaceutical composition containing Momordica charantia L. extracts for lowering blood glucose
|
|
US2010240887A1
|
|
New methods of producing HHT
|
|
US2007166415A1
|
|
Safe medicine for treating and preventing cancer and method of use
|
|
US2007059388A1
|
|
Pharmaceutical composition containing a safe extracts of plants for the treating and preventing of diabetes and cardiovascular disease
|
|
US2007059385A1
|
|
Safe pharmaceutical composition for treating and preventing cancer and method of use
|
|
CN1752021A
|
|
Method of producing ranadium pentoxide using vanadium containing waste catalyst
|
|
US5098710A
|
|
Production of kuguasu
|
|
US5086043A
|
|
Production of Saponins of Lichi
|
|
US4999343A
|
|
Production of polysaccharides and saponin of dangshen
|
|
US4985431A
|
|
Pharmaceutical composition for treating and preventing cardiovascular disease
|
|
US4999376A
|
|
Pharmaceutical composition for treating and preventing cardiovasular disease
|
|
US4985408A
|
|
Pharmaceutical composition for treating and preventing cardiovascular disease
|
|
US4944946A
|
|
Pharmaceutical composition for inhibiting viruses and increasing immune function (PII)
|
|
US4985247A
|
|
Pharmaceutical composition for inhibiting viruses and increasing immune function (PII)
|
|
US4985248A
|
|
Pharmaceutical composition containing a safe extracts of fruits and vegetables for the treating and preventing of diabetes
|
|
US5108750A
|
|
Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation
|
|
US4906471A
|
|
Pharmaceutical composition for the reducing both hyperlipidemia and platelet-aggregation (PHP)
|
|
US5071839A
|
|
Safe pharmaceutical composition for decreasing side effects of antiviral drugs and increasing the immune function (SDI) II
|
|
US4945115A
|
|
Process for preparing ferulic acid
|
